Clinical Trial Update: Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, safety, and tolerability of carbapenems in adults with pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: TASK Applied Science | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED